Accelerating UK MedTech innovation: what CPI learned through HealthTRIP and MARRS

(Image : CPI)

CPI reshaped how regulatory funding support is delivered in the UK, driving policy changes to better support SMEs on their market-access journeys.

Bringing a new medical device, including in vitro diagnostics (IVDs) or digital health, to market is never simple. Even the strongest technologies can stall when the regulatory pathway appears unclear or confusing. For early-stage innovators, navigating these steps alone can feel overwhelming, and choosing the correct regulatory approach is often the difference between an innovation reaching patients or disappearing before it ever has the chance.

Read more